These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14572535)

  • 1. Multidrug efflux pumps and resistance: regulation and evolution.
    Paulsen IT
    Curr Opin Microbiol; 2003 Oct; 6(5):446-51. PubMed ID: 14572535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug efflux pumps in Staphylococcus aureus and their clinical implications.
    Jang S
    J Microbiol; 2016 Jan; 54(1):1-8. PubMed ID: 26727895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple molecular mechanisms for multidrug resistance transporters.
    Higgins CF
    Nature; 2007 Apr; 446(7137):749-57. PubMed ID: 17429392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
    Guo A; Marinaro W; Hu P; Sinko PJ
    Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mystery of multidrug transporters: the answer can be simple.
    Neyfakh AA
    Mol Microbiol; 2002 Jun; 44(5):1123-30. PubMed ID: 12068801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MRP family of drug efflux pumps.
    Kruh GD; Belinsky MG
    Oncogene; 2003 Oct; 22(47):7537-52. PubMed ID: 14576857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistance in oncology and beyond: from imaging of drug efflux pumps to cellular drug targets.
    Nagengast WB; Oude Munnink TH; Dijkers EC; Hospers GA; Brouwers AH; Schröder CP; Lub-de Hooge M; de Vries EG
    Methods Mol Biol; 2010; 596():15-31. PubMed ID: 19949918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
    Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
    Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of efflux pump-based antibiotic resistance.
    Zgurskaya HI
    Int J Med Microbiol; 2002 Jul; 292(2):95-105. PubMed ID: 12195740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multidrug resistance-associated proteins and their roles in multidrug resistance].
    Zhang H; Fu LW
    Yao Xue Xue Bao; 2011 May; 46(5):479-86. PubMed ID: 21800532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of ATP-dependent solute transport by multidrug resistance-associated protein 1.
    Chang XB
    Methods Mol Biol; 2010; 596():223-49. PubMed ID: 19949927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural understanding of efflux-mediated drug resistance: potential routes to efflux inhibition.
    McKeegan KS; Borges-Walmsley MI; Walmsley AR
    Curr Opin Pharmacol; 2004 Oct; 4(5):479-86. PubMed ID: 15351352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1).
    Sauna ZE; Peng XH; Nandigama K; Tekle S; Ambudkar SV
    Mol Pharmacol; 2004 Mar; 65(3):675-84. PubMed ID: 14978246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein.
    Konings WN; Poelarends GJ
    IUBMB Life; 2002; 53(4-5):213-8. PubMed ID: 12120998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ABC transporter with a secondary-active multidrug translocator domain.
    Venter H; Shilling RA; Velamakanni S; Balakrishnan L; Van Veen HW
    Nature; 2003 Dec; 426(6968):866-70. PubMed ID: 14685244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis.
    De Rossi E; Arrigo P; Bellinzoni M; Silva PA; Martín C; Aínsa JA; Guglierame P; Riccardi G
    Mol Med; 2002 Nov; 8(11):714-24. PubMed ID: 12520088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug efflux pumps: the structures of prokaryotic ATP-binding cassette transporter efflux pumps and implications for our understanding of eukaryotic P-glycoproteins and homologues.
    Kerr ID; Jones PM; George AM
    FEBS J; 2010 Feb; 277(3):550-63. PubMed ID: 19961540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
    Eur J Pharmacol; 2000 Mar; 391(3):207-16. PubMed ID: 10729360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.